Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care
BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6977.441 (Published 18 February 1995) Cite this as: BMJ 1995;310:441- L M Mynors-Wallis, consultant psychiatrista,
- D H Gath, clinical readera,
- A R Lloyd-Thomas, research general practitionera,
- D Tomlinson, research general practitionera
- Correspondence to: Dr Mynors-Wallis.
- Accepted 12 January 1995
Abstract
Objective: To determine whether, in the treatment of major depression in primary care, a brief psychological treatment (problem solving) was (a) as effective as antidepressant drugs and more effective than placebo; (b) feasible in practice; and (c) acceptable to patients.
Design: Randomised controlled trial of problem solving treatment, amitriptyline plus standard clinical management, and drug placebo plus standard clinical management. Each treatment was delivered in six sessions over 12 weeks.
Setting: Primary care in Oxfordshire.
Subjects: 91 patients in primary care who had major depression.
Main outcome measures: Observer and self reported measures of severity of depression, self reported measure of social outcome, and observer measure of psychological symptoms at six and 12 weeks; self reported measure of patient satisfaction at 12 weeks. Numbers of patients recovered at six and 12 weeks.
Results: At six and 12 weeks the difference in score on the Hamilton rating scale for depression between problem solving and placebo treatments was significant (5.3 (95% confidence interval 1.6 to 9.0) and 4.7 (0.4 to 9.0) respectively), but the difference between problem solving and amitriptyline was not significant (1.8 (−1.8 to 5.5) and 0.9 (−3.3 to 5.2) respectively). At 12 weeks 60% (18/30) of patients given problem solving treatment had recovered on the Hamilton scale compared with 52% (16/31) given amitriptyline and 27% (8/30) given placebo. Patients were satisfied with problem solving treatment; all patients who completed treatment (28/30) rated the treatment as helpful or very helpful. The six sessions of problem solving treatment totalled a mean therapy time of 3 1/2 hours.
Conclusions: As a treatment for major depression in primary care, problem solving treatment is effective, feasible, and acceptable to patients.
Key messages
Key messages
Patient compliance with antidepressant treatment is often poor, so there is a need for a psychological treatment
This study found that problem solving is an effective psychological treatment for major depression in primary care—as effective as amitriptyline and more effective than placebo
Problem solving is a feasible treatment in primary care, being effective when given over six sessions by a general practitioner
Problem solving treatment is acceptable to patients
Footnotes
- Accepted 12 January 1995